STAGE III UTERINE CORPUS CANCER AJCC V7
Clinical trials for STAGE III UTERINE CORPUS CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III UTERINE CORPUS CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III UTERINE CORPUS CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests two drug combinations (olaparib plus either vistusertib or capivasertib) in people with recurrent endometrial, triple-negative breast, ovarian, or related cancers. The goal is to find the safest dose and see if the drugs can control tumor growth. About 159 adults…
Matched conditions: STAGE III UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
Heated chemo during surgery may fight recurrent ovarian cancer
Disease control OngoingThis early-phase study tests the safety and effectiveness of giving heated chemotherapy directly into the abdomen during surgery for advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants will receive this treatment, with some also get…
Matched conditions: STAGE III UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:01 UTC